Companies: 11,396     total market cap: A$212.953 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Moderna
MRNA
#221
Rank
A$149.21 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$368.78
Share price
5.27%
Change (1 day)
867.84%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech๐Ÿงฌ mRNA therapeutics
Categories
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

ESG Reports

Annual ReportsQuarterly ReportsESG ReportsAnnual Reports (10-K)Quarterly Reports (10-Q)
Thumbnail Moderna ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Moderna ESG Report 2022

ESG Report 2022

Language: English

View ESG Report

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com